Clinical Trial: Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736261) titled 'Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI' on July 22.

Brief Summary: Participants will:

* Take either drospirenone (a daily pill) or the standard daily injection during their ovarian stimulation cycle, alongside their regular fertility hormone injections

* Undergo egg retrieval, with all resulting embryos frozen (no fresh embryo transfer in this study)

* Have a frozen embryo transferred in a later cycle

* Complete two short questionnaires about their treatment experience - once before starting the injections/pills, and once after the stimula...